Status:

NOT_YET_RECRUITING

The GOS-Frail (Geriatric Oncology Supportive Care for Frail Older Adults With Cancer) Study

Lead Sponsor:

Tan Tock Seng Hospital

Collaborating Sponsors:

National University of Singapore

National Medical Research Council (NMRC), Singapore

Conditions:

Geriatric Oncology

Supportive Care

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

Background Cancer is more prevalent in older adults, but most cancer treatment trials have mainly involved young and healthy subjects. Among geriatric syndromes, frailty is a significant risk factor f...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Age ≥ 65
  • Diagnosis of solid organ cancer
  • Plan for curative-intent chemotherapy and/or radiotherapy
  • Clinical Frailty Scale (CFS) score ≥ 4,
  • Exclusion criteria: Evaluation by Geriatric or Palliative Medicine in the previous 6 months.

Exclusion

    Key Trial Info

    Start Date :

    September 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 31 2027

    Estimated Enrollment :

    154 Patients enrolled

    Trial Details

    Trial ID

    NCT06553378

    Start Date

    September 1 2024

    End Date

    August 31 2027

    Last Update

    August 14 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Tan Tock Seng Hospital

    Singapore, Singapore

    The GOS-Frail (Geriatric Oncology Supportive Care for Frail Older Adults With Cancer) Study | DecenTrialz